Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, APT Medical's Enterprise Value is ¥31,750 Mil.
APT Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥641 Mil. Therefore, APT Medical's EV-to-EBIT ratio for today is 49.50.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, APT Medical's Enterprise Value is ¥31,750 Mil.
APT Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥641 Mil. Therefore, APT Medical's EV-to-EBITDA ratio for today is 49.50.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, APT Medical's Enterprise Value is ¥31,750 Mil.
APT Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,756 Mil. Therefore, APT Medical's EV-to-Revenue ratio for today is 18.08.
APT Medical Enterprise Value Historical Data
The historical data trend for APT Medical's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of APT Medical's Enterprise Value
For the Medical Devices subindustry, APT Medical's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
APT Medical's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, APT Medical's Enterprise Value distribution charts can be found below:
* The bar in red indicates where APT Medical's Enterprise Value falls into.
APT Medical Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
APT Medical's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
APT Medical (SHSE:688617) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
APT Medical's current Enterprise Value is ¥31,750 Mil.
APT Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥641 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
APT Medical's current Enterprise Value is ¥31,750 Mil.
APT Medical's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥641 Mil.
APT Medical's current Enterprise Value is ¥31,750 Mil.
APT Medical's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,756 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
APT Medical Enterprise Value Related Terms
Thank you for viewing the detailed overview of APT Medical's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
APT Medical Inc is engaged in the research and development, production and sales of electrophysiological and vascular interventional medical devices for cardiovascular and cerebrovascular diseases. Its products are sold in Europe, Eastern Europe, Southeast Asia and other countries and other regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:688617 has been successfully added to your 